What are the pharmacologic considerations when treating depression in patients with HIV infection?
Swenson
J R
JR
Medical Psychiatric Unit, Ottawa General Hospital, University of Ottawa, Ont., Canada.
D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000697:Central Nervous System Stimulants / Q000008:administration & dosage / Q000627:therapeutic use; D015897:Comorbidity; D003866:Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology; D015658:HIV Infections / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008774:Methylphenidate / Q000008:administration & dosage / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D011570:Psychiatry / Q000379:methods
D000928:Antidepressive Agents; D000697:Central Nervous System Stimulants; D008774:Methylphenidate